Showing results (141-150 of 389) with videos related to
Sort By:
Pageof 39
ERJ Open Research|October 18, 2023
Altered macrophage phenotypes in a case of autoimmune pulmonary alveolar proteinosisKentaro Hata, Toyoshi Yanagihara, Keisuke Matsubara, et al.Therapeutic Drug Monitoring|January 19, 2006
Pharmacokinetics of amrubicin and its active metabolite amrubicinol in lung cancer patientsYusuke Matsunaga, Akinobu Hamada, Isamu Okamoto, et al.Internal Medicine (Tokyo, Japan)|April 7, 2011
Malignant pleural effusion from lung adenocarcinoma treated by gefitinibAkihito Kubo, Yasuhiro Koh, Tomoya Kawaguchi, et al.Cancer Science|October 7, 2009
Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplificationTakeshi Yoshida, Isamu Okamoto, Wataru Okamoto, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Large cell neuroendocrine carcinoma of the mediastinum with alpha-fetoprotein productionKen Takezawa, Isamu Okamoto, Junya Fukuoka, et al.European Journal of Cancer (Oxford, England : 1990)|October 2, 2024
Nivolumab plus ipilimumab with chemotherapy for non-small cell lung cancer with untreated brain metastases: A multicenter single-arm phase 2 trial (NIke, LOGiK 2004)Yuko Tsuchiya-Kawano, Yoshimasa Shiraishi, Kentaro Tanaka, et al.Cancer Science|October 30, 2008
Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancerRyotaro Morinaga, Isamu Okamoto, Yoshihiko Fujita, et al.Lung Cancer (Amsterdam, Netherlands)|April 3, 2013
Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancerMiyako Satouchi, Isamu Okamoto, Hiroshi Sakai, et al.Oncotarget|January 19, 2013
MET amplification as a potential therapeutic target in gastric cancerHisato Kawakami, Isamu Okamoto, Tokuzo Arao, et al.Cancer Science|January 31, 2013
Sorting nexin 2-mediated membrane trafficking of c-Met contributes to sensitivity of molecular-targeted drugsSayaka Ogi, Hideaki Fujita, Masaki Kashihara, et al.Pageof 39